Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens

Míreanna comhchosúla

• Is increasing pretreatment HIV drug resistance a real menace or minor detail?
  de réir: Inzaule, SC, et al.
  Foilsithe / Cruthaithe: (2020)
• Does tenofovir-containing first-line antiretroviral therapy mitigate the impact of pretreatment non-nucleoside reverse transcriptase inhibitor drug resistance?
  de réir: Inzaule, SC, et al.
  Foilsithe / Cruthaithe: (2018)
• HIV drug resistance in low-income and middle-income countries
  de réir: Hamers, R, et al.
  Foilsithe / Cruthaithe: (2018)
• Need assessment for HIV drug resistance testing and landscape of current and future technologies in low- and middle-income countries.
  de réir: Neil Parkin, et al.
  Foilsithe / Cruthaithe: (2023-01-01)
• Antibiotic consumption in low-income and middle-income countries
  de réir: Hamers, R, et al.
  Foilsithe / Cruthaithe: (2018)